Paper · 31743079

Regulation and Effects of FGF23 in Chronic Kidney Disease.

Musgrove J and 1 other. Annu Rev Physiol, 2020. Cited by 105 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Regulation and Effects of FGF23 in Chronic Kidney Disease. Papers, record 31743079. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31743079

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Regulation and Effects of FGF23 in Chronic Kidney Disease.; PubMed
Journal: Annu Rev Physiol; PubMed
Year: 2020; PubMed
Publication types: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/31743079/; PubMed
DOI: https://doi.org/10.1146/annurev-physiol-021119-034650; PubMed
The journal: https://conductscience.org/library/journal-index/0370600; PubMed
Citations, by iCite: 105; iCite
Relative citation ratio, by iCite: 6.13; iCite
Revised in PubMed: 2021-12-04; PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename	Kind	ORCID iD
1	Musgrove J	John
2	Wolf M	Myles

Source PubMed

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Fibroblast Growth Factors	Major topic
Renal Insufficiency, Chronic	Major topic
Animals
Fibroblast Growth Factor-23
Humans

Source PubMed

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes it	Agency	Country	NIH project	Stated by	Source
R01 DK076116	NIDDK NIH HHS	United States	R01DK076116	PubMed and NIH	NIH RePORTER
R01 DK081374	NIDDK NIH HHS	United States	R01DK081374	PubMed and NIH	NIH RePORTER
UG3 DK118748	NIDDK NIH HHS	United States	UG3DK118748	PubMed and NIH	NIH RePORTER
U01 DK099930	NIDDK NIH HHS	United States	U01DK099930	PubMed and NIH	NIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by81

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 105 citations.

PMID	Title	Journal	Year	In Papers	Source
42,797,299	Pharmaceutical Strategies for Translating Klotho-Based Therapeutics: From Biologic Developability to Advanced Delivery Systems.	Pharmaceutics	2026	https://conductscience.org/library/papers/42797299	PubMed
42,646,627	Temporomandibular Joint Abnormalities in Hemodialysis Patients: A Cross-Sectional Ultrasonographic Study from a Single Center in Italy.	Med Sci (Basel)	2026	https://conductscience.org/library/papers/42646627	PubMed
42,626,629	Combined effects of diet and genetic predisposition on kidney function outcomes.	Clin Kidney J	2026	https://conductscience.org/library/papers/42626629	PubMed
42,238,242	Fibroblast growth factor 23 levels and the risk of diabetic kidney disease: a systematic review and meta-analysis.	Front Endocrinol (Lausanne)	2026	https://conductscience.org/library/papers/42238242	PubMed
42,106,700	Association between air pollution exposure and increased chronic kidney disease risk: the modifying effects of genetic susceptibility, transcriptomic, and proteomic signatures.	BMC Med	2026	https://conductscience.org/library/papers/42106700	PubMed
41,972,542	FGF23 Controls Myocardial Fibrosis Progression via Promoting Cardiac Fibroblast Proliferation and Activation in Mice.	Biology (Basel)	2026	https://conductscience.org/library/papers/41972542	PubMed
41,832,306	FGF family in health and disease.	Mol Biomed	2026	https://conductscience.org/library/papers/41832306	PubMed
41,767,622	Markers of Mineral Metabolism in Children With CKD Stages 2 to 5D.	Kidney Int Rep	2026	https://conductscience.org/library/papers/41767622	PubMed
41,426,862	Effects of Fibroblast Growth Factor 23 (FGF23) on the Cardiovascular System: A Review of Literature.	Cureus	2025	https://conductscience.org/library/papers/41426862	PubMed
40,189,543	Risk factors for and a preliminary prediction model of coronary artery calcification in patients beginning hemodialysis.	Eur J Med Res	2025	https://conductscience.org/library/papers/40189543	PubMed

1 to 10 of 81

See all 81 cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Gene	NCBI Gene ID	Linked by	In Genes
FGF23	8,074	PubTator's text mining	https://conductscience.org/library/genes/8074

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31743079

GET https://conductscience.org/api/papers/v1/31743079/cited_by?page=2

API reference For AI assistants